Cargando…

Microparticles: A New Perspective in Central Nervous System Disorders

Microparticles (MPs) are a heterogeneous population of small cell-derived vesicles, ranging in size from 0.1 to 1 μm. They contain a variety of bioactive molecules, including proteins, biolipids, and nucleic acids, which can be transferred between cells without direct cell-to-cell contact. Consequen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schindler, Stephanie M., Little, Jonathan P., Klegeris, Andis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000927/ https://www.ncbi.nlm.nih.gov/pubmed/24860829 http://dx.doi.org/10.1155/2014/756327

Ejemplares similares

Regulation of the phagocytic activity of astrocytes by neuroimmune mediators endogenous to the central nervous system
por: Yang, Sijie (Shirley), et al.
Publicado: (2023)

A new look at auranofin, dextromethorphan and rosiglitazone for reduction of glia-mediated inflammation in neurodegenerative diseases
por: Madeira, Jocelyn M., et al.
Publicado: (2015)

Regulation of neuroimmune processes by damage- and resolution-associated molecular patterns
por: Klegeris, Andis
Publicado: (2020)

Neuroinflammation as a mechanism linking hypertension with the increased risk of Alzheimer’s disease
por: Bajwa, Ekta, et al.
Publicado: (2022)

Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer’s Disease
por: Hashioka, Sadayuki, et al.
Publicado: (2021)

The Role of Mitochondrial Damage-Associated Molecular Patterns in Chronic Neuroinflammation
por: Bajwa, Ekta, et al.
Publicado: (2019)

Clinical perspectives of TRAIL: insights into central nervous system disorders
por: Tisato, Veronica, et al.
Publicado: (2016)

Improvement in Generic Problem-Solving Abilities of Students by Use of Tutor-less Problem-Based Learning in a Large Classroom Setting
por: Klegeris, Andis, et al.
Publicado: (2013)

The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ
por: Klegeris, Andis, et al.
Publicado: (2012)

Modulation of microglial functions by methyl jasmonate
por: McKenzie, Jordan A., et al.
Publicado: (2018)

Zinc and Central Nervous System Disorders
por: Wang, Bangqi, et al.
Publicado: (2023)

Drugs in Central Nervous System Disorders
por: Perry, Bruce D.
Publicado: (1985)

Human oligodendroglial cells express low levels of C1 inhibitor and membrane cofactor protein mRNAs
por: Hosokawa, Masato, et al.
Publicado: (2004)

Autoimmune channelopathies: new antibody-mediated disorders of the central nervous system
por: Vincent, Angela
Publicado: (2009)

Role of Adiponectin in Central Nervous System Disorders
por: Bloemer, Jenna, et al.
Publicado: (2018)

Regulators of cholinergic signaling in disorders of the central nervous system
por: Winek, Katarzyna, et al.
Publicado: (2021)

Beneficial Effects of Capsaicin in Disorders of the Central Nervous System
por: Pasierski, Michał, et al.
Publicado: (2022)

Paraneoplastic Diseases of the Central Nervous System
por: Galli, Jonathan, et al.
Publicado: (2020)

Probenecid, an Old Drug with Potential New Uses for Central Nervous System Disorders and Neuroinflammation
por: García-Rodríguez, Claudia, et al.
Publicado: (2023)

The lymphatic system: a therapeutic target for central nervous system disorders
por: Xu, Jia-Qi, et al.
Publicado: (2022)

Purinergic responses of calcium-dependent signaling pathways in cultured adult human astrocytes
por: Hashioka, Sadayuki, et al.
Publicado: (2014)

Nanomedicine-based immunotherapy for central nervous system disorders
por: Hanif, Sumaira, et al.
Publicado: (2020)

Neurometabolic disorders and congenital malformations of the central nervous system
por: BoAli, Ahmed Y., et al.
Publicado: (2018)

Mucormycosis of the Central Nervous System
por: Chikley, Amanda, et al.
Publicado: (2019)

Deoxyribozymes: New Therapeutics to Treat Central Nervous System Disorders
por: Grimpe, Barbara
Publicado: (2011)

Intercellular mitochondrial transfer in the brain, a new perspective for targeted treatment of central nervous system diseases
por: Geng, Ziang, et al.
Publicado: (2023)

New Insights into ADAMTS Metalloproteases in the Central Nervous System
por: Mohamedi, Yamina, et al.
Publicado: (2020)

Update on Atypicalities of Central Nervous System in Autism Spectrum Disorder
por: Shuid, Ahmad Naqib, et al.
Publicado: (2020)

Imaging of Central Nervous System Involvement in Pediatric Hematologic Disorders
por: Kalın, Sevinç, et al.
Publicado: (2022)

Extracellular vesicle therapy for traumatic central nervous system disorders
por: Zhang, Jing, et al.
Publicado: (2022)

Inflammatory Disorders of the Central Nervous System Vessels: Narrative Review
por: Ekkert, Aleksandra, et al.
Publicado: (2022)

Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System
por: Panchal, Sunil K., et al.
Publicado: (2022)

Primary Central Nervous System Lymphoma in Elderly Patients: Management and Perspectives
por: Morales-Martinez, Andrea, et al.
Publicado: (2021)

Demyelinating Disorders of the Central Nervous System
por: Pirko, Istvan, et al.
Publicado: (2007)

Mitochondria and Central Nervous System Disorders
por: Knedlik, Tomas, et al.
Publicado: (2022)

Benefits of hesperidin in central nervous system disorders: a review
por: Kim, Jeongtae, et al.
Publicado: (2019)

Epidrugs in the Therapy of Central Nervous System Disorders: A Way to Drive on?
por: Gladkova, Marina G., et al.
Publicado: (2023)

Neuromyelitis Optica: An Antibody-Mediated Disorder of the Central Nervous System
por: Oh, Jiwon, et al.
Publicado: (2012)

Cholesterol: Its Regulation and Role in Central Nervous System Disorders
por: Orth, Matthias, et al.
Publicado: (2012)

Sex and Gender Differences in Central Nervous System-Related Disorders
por: Zagni, Emanuela, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fa7ua63kpoe4mcck0q203kca67